Supplementary Table S1 from The Discovery and Characterization of HBS-101, a Novel Inhibitor of Midkine, as a Therapeutic Agent for the Treatment of Triple-Negative Breast Cancer

Supplementary Table S1 from The Discovery and Characterization of HBS-101, a Novel Inhibitor of Midkine, as a Therapeutic Agent for the Treatment of Triple-Negative Breast Cancer

<p>Supplementary Table S1. List of Antibodies used</p>

Saved in:
Bibliographic Details
Main Author: Megharani Mahajan (19810332) (author)
Other Authors: Alondra L. Rodriguez Sanchez (22164781) (author), Sridharan Jayamohan (22164784) (author), Dileep K. Vijayan (22164787) (author), Jessica D. Johnson (22164790) (author), Huan Xie (17316659) (author), Yang Wang (22164793) (author), Dong Liang (15107744) (author), John R. Sanchez (14958717) (author), Panneerdoss Subbarayalu (22164796) (author), Manjeet K. Rao (14956450) (author), Ratna K. Vadlamudi (12394034) (author), Gangadhara R. Sareddy (14958741) (author), Hareesh B. Nair (22164799) (author), Suryavathi Viswanadhapalli (14958693) (author)
Published: 2025
Subjects:
Cancer
Tumor Biology
Molecular and Cellular Biology
Therapeutic Research and Development
Breast Cancer
Cell Signaling
Drug Targets
Progression, Invasion & Metastasis
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items